Biotechs were showing signs that they were about to move. The RS (relative strength) Rating Line was rising and buying volume was picking up, so I bought the sector before the actual breakout. Consequently, we were well positioned to benefit from this breakout.
(click on the charts for easier viewing)
Biotech Index
The blue shaded box is the buy zone. |
GWM Model Portfolios hold multiple positions that are biotech related.
Gilead (GILD)
Celegene (CELG)
IShare Biotech Index ETF (BBI)
This blog post does not constitute an offer of investment advice. This blog is only provided for educational purposes. Please read the Important Blog Disclosure posted in the right channel bar.
No comments:
Post a Comment